Paclitaxel, Topotecan, and Estramustine in Treating Patients With Metastatic Hormone-Refractory Prostate Cancer

NCT00084565 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped Study was never activated at Fox Chase Cancer Center.

Conditions

Prostate Cancer

Interventions

DRUG: estramustine phosphate sodium
DRUG: paclitaxel
DRUG: topotecan hydrochloride

Sponsor

Fox Chase Cancer Center